Literature DB >> 27197180

NOTCH Signaling Regulates Asymmetric Cell Fate of Fast- and Slow-Cycling Colon Cancer-Initiating Cells.

Tara Srinivasan1, Jewell Walters2, Pengcheng Bu3, Elaine Bich Than2, Kuei-Ling Tung4, Kai-Yuan Chen5, Nicole Panarelli2, Jeff Milsom2, Leonard Augenlicht6, Steven M Lipkin7, Xiling Shen8.   

Abstract

Colorectal cancer cells with stem-like properties, referred to as colon cancer-initiating cells (CCIC), have high tumorigenic potential. While CCIC can differentiate to promote cellular heterogeneity, it remains unclear whether CCIC within a tumor contain distinct subpopulations. Here, we describe the co-existence of fast- and slow-cycling CCIC, which can undergo asymmetric division to generate each other, highlighting CCIC plasticity and interconvertibility. Fast-cycling CCIC express markers, such as LGR5 and CD133, rely on MYC for their proliferation, whereas slow-cycling CCIC express markers, such as BMI1 and hTERT, are independent of MYC. NOTCH signaling promotes asymmetric cell fate, regulating the balance between these two populations. Overall, our results illuminate the basis for CCIC heterogeneity and plasticity by defining a direct interconversion mechanism between slow- and fast-cycling CCIC. Cancer Res; 76(11); 3411-21. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27197180      PMCID: PMC4891252          DOI: 10.1158/0008-5472.CAN-15-3198

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  43 in total

1.  LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling.

Authors:  Andrei Glinka; Christine Dolde; Nadine Kirsch; Ya-Lin Huang; Olga Kazanskaya; Dierk Ingelfinger; Michael Boutros; Cristina-Maria Cruciat; Christof Niehrs
Journal:  EMBO Rep       Date:  2011-09-30       Impact factor: 8.807

Review 2.  The Notch signaling pathway as a mediator of tumor survival.

Authors:  Kathleen M Capaccione; Sharon R Pine
Journal:  Carcinogenesis       Date:  2013-04-12       Impact factor: 4.944

3.  gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.

Authors:  Raymond D Meng; Christopher C Shelton; Yue-Ming Li; Li-Xuan Qin; Daniel Notterman; Philip B Paty; Gary K Schwartz
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

Review 4.  Dividing cellular asymmetry: asymmetric cell division and its implications for stem cells and cancer.

Authors:  Ralph A Neumüller; Juergen A Knoblich
Journal:  Genes Dev       Date:  2009-12-01       Impact factor: 11.361

5.  A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells.

Authors:  Pengcheng Bu; Kai-Yuan Chen; Joyce Huan Chen; Lihua Wang; Jewell Walters; Yong Jun Shin; Julian P Goerger; Jian Sun; Mavee Witherspoon; Nikolai Rakhilin; Jiahe Li; Herman Yang; Jeff Milsom; Sang Lee; Warren Zipfel; Moonsoo M Jin; Zeynep H Gümüş; Steven M Lipkin; Xiling Shen
Journal:  Cell Stem Cell       Date:  2013-05-02       Impact factor: 24.633

6.  Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

Authors:  Emina H Huang; Mark J Hynes; Tao Zhang; Christophe Ginestier; Gabriela Dontu; Henry Appelman; Jeremy Z Fields; Max S Wicha; Bruce M Boman
Journal:  Cancer Res       Date:  2009-03-31       Impact factor: 12.701

7.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

8.  The spatial distribution of LGR5+ cells correlates with gastric cancer progression.

Authors:  Eva Simon; Diana Petke; Christine Böger; Hans-Michael Behrens; Viktoria Warneke; Matthias Ebert; Christoph Röcken
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

9.  Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting.

Authors:  Huanhuan Joyce Chen; Jian Sun; Zhiliang Huang; Harry Hou; Myra Arcilla; Nikolai Rakhilin; Daniel J Joe; Jiahn Choi; Poornima Gadamsetty; Jeff Milsom; Govind Nandakumar; Randy Longman; Xi Kathy Zhou; Robert Edwards; Jonlin Chen; Kai Yuan Chen; Pengcheng Bu; Lihua Wang; Yitian Xu; Robert Munroe; Christian Abratte; Andrew D Miller; Zeynep H Gümüş; Michael Shuler; Nozomi Nishimura; Winfried Edelmann; Xiling Shen; Steven M Lipkin
Journal:  Nat Biotechnol       Date:  2015-05-25       Impact factor: 54.908

10.  Brief report: CD24 and CD44 mark human intestinal epithelial cell populations with characteristics of active and facultative stem cells.

Authors:  Adam D Gracz; Megan K Fuller; Fengchao Wang; Linheng Li; Matthias Stelzner; James C Y Dunn; Martin G Martin; Scott T Magness
Journal:  Stem Cells       Date:  2013-09       Impact factor: 5.845

View more
  18 in total

Review 1.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

Review 2.  Environmental Impact on Intestinal Stem Cell Functions in Mucosal Homeostasis and Tumorigenesis.

Authors:  Leonard H Augenlicht
Journal:  J Cell Biochem       Date:  2017-01-11       Impact factor: 4.429

Review 3.  Applications of tumor chip technology.

Authors:  Stephanie J Hachey; Christopher C W Hughes
Journal:  Lab Chip       Date:  2018-09-26       Impact factor: 6.799

Review 4.  Asymmetric Cell Division and Tumor Heterogeneity.

Authors:  Zizhu Li; Ying Yi Zhang; Haomiao Zhang; Jiaxuan Yang; Yongze Chen; Hezhe Lu
Journal:  Front Cell Dev Biol       Date:  2022-07-04

5.  Independent and core pathways in oncogenic KRAS signaling.

Authors:  Ruth Nussinov; Chung-Jung Tsai; Hyunbum Jang
Journal:  Expert Rev Proteomics       Date:  2016-07-18       Impact factor: 3.940

Review 6.  Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis.

Authors:  Sukanya Basu; Yang Dong; Rahul Kumar; Collene Jeter; Dean G Tang
Journal:  Semin Cancer Biol       Date:  2021-05-09       Impact factor: 15.707

7.  Identification and Characterization of Cancer Cells That Initiate Metastases to the Brain and Other Organs.

Authors:  Anna S Berghoff; Yunxiang Liao; Matthia A Karreman; Ayseguel Ilhan-Mutlu; Katharina Gunkel; Martin R Sprick; Christian Eisen; Tobias Kessler; Matthias Osswald; Susanne Wünsche; Manuel Feinauer; Brunhilde Gril; Frederic Marmé; Laura L Michel; Zuszanna Bago-Horvath; Felix Sahm; Natalia Becker; Michael O Breckwoldt; Gergely Solecki; Miriam Gömmel; Lulu Huang; Petra Rübmann; Carina M Thome; Miriam Ratliff; Andreas Trumpp; Patricia S Steeg; Matthias Preusser; Wolfgang Wick; Frank Winkler
Journal:  Mol Cancer Res       Date:  2020-12-22       Impact factor: 6.333

8.  Quercetin-induced miR-200b-3p regulates the mode of self-renewing divisions in pancreatic cancer.

Authors:  Clifford C Nwaeburu; Alia Abukiwan; Zhefu Zhao; Ingrid Herr
Journal:  Mol Cancer       Date:  2017-01-31       Impact factor: 27.401

9.  CUL4B contributes to cancer stemness by repressing tumor suppressor miR34a in colorectal cancer.

Authors:  Yanjun Li; Huili Hu; Yuxing Wang; Yujia Fan; Yang Yang; Beibei Guo; Xueyong Xie; Jiabei Lian; Baichun Jiang; Bo Han; Yanlei Wang; Changshun Shao; Yaoqin Gong
Journal:  Oncogenesis       Date:  2020-02-13       Impact factor: 7.485

10.  A set of cancer stem cell homing peptides associating with the glycan moieties of glycosphingolipids.

Authors:  Yu-Hsiu Su; Tai-Yun Lin; Hung-Jen Liu; Chin-Kai Chuang
Journal:  Oncotarget       Date:  2018-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.